BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

LIVE

Serial Number

97715574

Owner

TG Therapeutics, Inc.

Attorney

Maury M. Tepper, III

First Use Date

Jun 12, 2023

Filing Date

Dec 13, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV Trademark

Serial Number: 97715574 • Registration: 7627245

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV is a trademark filed by TG Therapeutics, Inc. on December 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

TG Therapeutics, Inc. (31 trademarks)

New York, NY 10014

Entity Type: 03

Legal Representation

Attorney of Record

Maury M. Tepper, III

5,883 trademarks filed View all →

Trademark Details

Filing Date

December 13, 2022

Registration Date

December 24, 2024

First Use Anywhere

June 12, 2023

First Use in Commerce

June 12, 2023

Published for Opposition

July 11, 2023

Goods & Services

pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases, the foregoing featuring monoclonal antibodies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 24, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Dec 24, 2024 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 3, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 3, 2024 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Nov 5, 2024 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 5, 2024 AITU

USE AMENDMENT FILED

Sep 4, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 4, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 5, 2024 EXRA

SOU EXTENSION 1 GRANTED

Mar 4, 2024 EX1G

SOU EXTENSION 1 FILED

Mar 4, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 4, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 5, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 11, 2023 NPUB

PUBLISHED FOR OPPOSITION

Jul 11, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 21, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 7, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 6, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 6, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 6, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 9, 2023 GNRN

NON-FINAL ACTION E-MAILED

Mar 9, 2023 GNRT

NON-FINAL ACTION WRITTEN

Mar 9, 2023 CNRT

ASSIGNED TO EXAMINER

Mar 8, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 11, 2023 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 10, 2023 NWOS

NEW APPLICATION ENTERED

Dec 16, 2022 NWAP

Related Trademarks

More from this Owner

BRIUMVI-ONE

BRIUMVI ONE

NEXT IN MS

NEXT... IN MS

More in Same Class